About
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
Key Metrics
as of Sep 2026Market Cap140 Cr
P/E57.60
Div Yield0.00 %
Book Value₹45.10
52w High₹47.80
52w Low₹15.20
Face Value₹2.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80.68 | 70.71 | 72.54 | 56.18 | 70.74 | 76.27 | 73.29 | 77.38 | 65.62 | 59.83 | 60.79 | 54.72 | 65.96 |
| Expenses | 76.02 | 70.59 | 69.45 | 55.02 | 66.58 | 63.72 | 69.30 | 66.79 | 55.53 | 46.36 | 47.14 | 43.96 | 57.12 |
| Operating Profit | 4.66 | 0.12 | 3.09 | 1.16 | 4.16 | 12.55 | 3.99 | 10.59 | 10.09 | 13.47 | 13.65 | 10.76 | 8.84 |
| OPM % | 5.78 | 0.17 | 4.26 | 2.06 | 5.88 | 16.45 | 5.44 | 13.69 | 15.38 | 22.51 | 22.45 | 19.66 | 13.40 |
| Other Income | -0.99 | 2.92 | 0.10 | 1.59 | -1.78 | -1.69 | 3.94 | -4.11 | -1.85 | -0.70 | 1.51 | 5.93 | -47.68 |
| Depreciation | 0.85 | 0.65 | 0.56 | 0.48 | 0.46 | 0.46 | 0.48 | 0.46 | 0.49 | 0.67 | 0.48 | 0.66 | 0.29 |
| Interest | 0.73 | 0.99 | 1.02 | 0.89 | 1.01 | 0.74 | 1.38 | 0.45 | 0.37 | 0.61 | 0.41 | 0.37 | 0.29 |
| Profit before tax | 2.09 | 1.40 | 1.61 | 1.38 | 0.91 | 9.66 | 6.07 | 5.57 | 7.38 | 11.49 | 14.27 | 15.66 | -39.42 |
| Tax % | 38.28 | 56.43 | 80.75 | 84.06 | 67.03 | 10.56 | 11.70 | 17.41 | 12.06 | 4.87 | 4.77 | 7.92 | 4.90 |
| Net Profit | 1.30 | 0.61 | 0.31 | 0.21 | 0.29 | 8.64 | 5.36 | 4.59 | 6.48 | 10.93 | 13.59 | 14.43 | -41.34 |
| EPS in Rs | 0.24 | 0.11 | 0.06 | 0.04 | 0.05 | 1.57 | 0.97 | 0.83 | 1.17 | 2.01 | 2.65 | 2.82 | -8.07 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 270.00 | 293.00 | 241.00 | 336.00 | 279.00 | 231.00 | 46.00 | 14.00 |
| Expenses | 262.00 | 260.00 | 197.00 | 279.00 | 229.00 | 189.00 | 37.00 | 12.00 |
| Operating Profit | 9.00 | 32.00 | 45.00 | 57.00 | 51.00 | 43.00 | 8.00 | 2.00 |
| OPM % | 3.20 | 11.00 | 18.00 | 17.00 | 18.00 | 18.00 | 18.00 | 11.00 |
| Other Income | 3.00 | 2.00 | -38.00 | 3.00 | 5.00 | 2.00 | 1.00 | 1.00 |
| Interest | 4.00 | 4.00 | 3.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 5.00 | 29.00 | 2.00 | 57.00 | 55.00 | 44.00 | 9.00 | 2.00 |
| Tax % | 73.00 | 13.00 | 219.00 | 19.00 | 13.00 | 14.00 | 31.00 | 19.00 |
| Net Profit | 1.00 | 25.00 | -2.00 | 46.00 | 48.00 | 38.00 | 6.00 | 2.00 |
| EPS in Rs | 0.26 | 4.54 | -0.44 | 9.03 | 9.53 | 7.63 | 1.22 | 1.30 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.00 | 11.00 | 11.00 | 10.00 | 10.00 | 10.00 | 10.00 | 3.00 |
| Reserves | 238.00 | 221.00 | 190.00 | 173.00 | 103.00 | 55.00 | 18.00 | 0.00 |
| Borrowings | 58.00 | 53.00 | 19.00 | 13.00 | 4.00 | 4.00 | 0.00 | 0.00 |
| Other Liabilities | 30.00 | 25.00 | 38.00 | 43.00 | 60.00 | 31.00 | 8.00 | 3.00 |
| Total Liabilities | 337.00 | 310.00 | 258.00 | 240.00 | 176.00 | 100.00 | 36.00 | 6.00 |
| Fixed Assets | 82.00 | 41.00 | 41.00 | 41.00 | 29.00 | 2.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 22.00 | 2.00 | 3.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 0.00 | 0.00 |
| Other Assets | 255.00 | 247.00 | 215.00 | 195.00 | 147.00 | 94.00 | 36.00 | 6.00 |
| Total Assets | 337.00 | 310.00 | 258.00 | 240.00 | 176.00 | 100.00 | 36.00 | 6.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -4.00 | -35.00 | 5.00 | 6.00 | 34.00 | 0.00 | -14.00 | -2.00 |
| Cash from Investing Activity | -21.00 | -22.00 | -1.00 | -11.00 | -28.00 | -6.00 | 0.00 | 0.00 |
| Cash from Financing Activity | 0.00 | 34.00 | 30.00 | 26.00 | 0.00 | 4.00 | 18.00 | 0.00 |
| Net Cash Flow | -25.00 | -23.00 | 34.00 | 21.00 | 6.00 | -2.00 | 4.00 | -2.00 |
| Free Cash Flow | -25.00 | -57.00 | 4.00 | -9.00 | 7.00 | -3.00 | -14.00 | -2.00 |
| CFO/OP % | 3.00 | -98.00 | 26.00 | 32.00 | 78.00 | 6.00 | -161.00 | -97.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184.00 | 138.00 | 84.00 | 57.00 | 36.00 | 121.00 | 238.00 | 147.00 |
| Inventory Days | 202.00 | 173.00 | 233.00 | 189.00 | 184.00 | 29.00 | 9.00 | — |
| Days Payable | 51.00 | 36.00 | 82.00 | 62.00 | 92.00 | 53.00 | 64.00 | — |
| Cash Conversion Cycle | 335.00 | 275.00 | 235.00 | 184.00 | 129.00 | 97.00 | 183.00 | 147.00 |
| Working Capital Days | 236.00 | 186.00 | 142.00 | 122.00 | 92.00 | 91.00 | 181.00 | 82.00 |
| ROCE % | 3.00 | 13.00 | 21.00 | 37.00 | 60.00 | 93.00 | 57.00 | — |
Corporate Actions
4 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Split | 30 May 2024 | 30 May 2024 | 10:2 | — | |
| Dividend | 01 Jul 2022 | 04 Jul 2022 | — | 0.50 | |
| Other | 21 Sep 2017 | — | — | — | Annual General Meeting |
| Other | 22 Sep 2016 | — | — | — | Annual General Meeting |
Announcements
5 filingsAnnual Reports
Credit Ratings
-
Rating update1 Apr from crisil
-
Rating update13 Nov 2025 from crisil
-
Rating update5 Nov 2024 from crisil
-
Rating update14 Aug 2023 from crisil
-
Rating update7 Sep 2022 from crisil